Tau cleavage and tau aggregation in neurodegenerative disease

Biochemical Society Transactions

Volumn 38, Issue 4, 2010, Pages 1016-1020

  Hanger, Diane P ^a   Wray, Selina ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dementia; Phosphorylation; Protein aggregation; Proteolysis; Tau; Tauopathy

Indexed keywords

AMINOPEPTIDASE; CALPAIN; CASPASE; CATHEPSIN; ISOPROTEIN; PROTEINASE; PUROMYCIN SENSITIVE AMINOPEPTIDASE; TAU PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BRAIN; DEGENERATIVE DISEASE; HUMAN; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CLEAVAGE; REVIEW; TAUOPATHY;

ANIMALS; CHEMICAL PRECIPITATION; DISEASE MODELS, ANIMAL; HUMANS; NEURODEGENERATIVE DISEASES; PEPTIDE HYDROLASES; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS;

EID: 77955943958     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0381016     Document Type: Review

References (51)

1. Hanger, D.P., Anderton, B.H. and Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112-119
2. Burbank, K.S. and Mitchison, T.J. (2006) Microtubule dynamic instability. Curr. Biol. 16, R516-R517
3. Hanger, D.P., Seereeram, A. and Noble, W. (2009) Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev. Neurother. 9, 1647-1666
4. Garcia-Sierra, F., Mondragon-Rodriguez, S. and Basurto-Islas, G. (2008) Truncation of tau protein and its pathological significance in Alzheimer's disease. J. Alzheimer's Dis. 14, 401-409
5. Gamblin, T.C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A.L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N. et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 10032-10037
6. Novak, M., Kabat, J. and Wischik, C.M. (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12, 365-370 (Pubitemid 23042416)
7. Rissman, R.A., Poon, W.W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M.P., LaFerla, F.M., Rohn, T.T. and Cotman, C.W. (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121-130
8. Guillozet-Bongaarts, A.L., Garcia-Sierra, F., Reynolds, M.R., Horowitz, P.M., Fu, Y., Wang, T., Cahill, M.E., Bigio, E.H., Berry, R.W. and Binder, L.I. (2005) Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol. Aging 26, 1015-1022 (Pubitemid 40312665)
9. Robertson, J., Loviny, T.L., Goedert, M., Jakes, R., Murray, K.J., Anderton, B.H. and Hanger, D.P. (1993) Phosphorylation of tau by cyclic-AMP-dependent protein kinase. Dementia 4, 256-263 (Pubitemid 23281686)
10. Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.-P. and Anderton, B.H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62
11. Guillozet-Bongaarts, A.L., Cahill, M.E., Cryns, V.L., Reynolds, M.R., Berry, R.W. and Binder, L.I. (2006) Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. J. Neurochem. 97, 1005-1014
12. Guillozet-Bongaarts, A.L., Glajch, K.E., Libson, E.G., Cahill, M.E., Bigio, E., Berry, R.W. and Binder, L.I. (2007) Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol. 113, 513-520 (Pubitemid 46672597)
13. Cho, J.H. and Johnson, G.V. (2004) Glycogen synthase kinase 3β induces caspase-cleaved tau aggregation in situ. J. Biol. Chem. 279, 54716-54723
14. Amadoro, G., Corsetti, V., Ciotti, M.T., Florenzano, F., Capsoni, S., Amato, G. and Calissano, P. (2009) Endogenous Aβ causes cell death via early tau hyperphosphorylation. Neurobiol. Aging, doi:10.1016/j.neurobiolaging. 2009.06.005
15. Park, S.Y. and Ferreira, A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration. J. Neurosci. 25, 5365-5375
16. Canu, N., Dus, L., Barbato, C., Ciotti, M.T., Brancolini, C., Rinaldi, A.M., Novak, M., Cattaneo, A., Bradbury, A. and Calissano, P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18, 7061-7074
17. Arai, T., Ikeda, K., Akiyama, H., Tsuchiya, K., Yagishita, S. and Takamatsu, J. (2001) Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy. NeuroReport 12, 935-938 (Pubitemid 32281450)
18. Arai, T., Ikeda, K., Akiyama, H., Nonaka, T., Hasegawa, M., Ishiguro, K., Iritani, S., Tsuchiya, K., Iseki, E., Yagishita, S. et al. (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann. Neurol. 55, 72-79
19. Wray, S., Saxton, M., Anderton, B.H. and Hanger, D.P. (2008) Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. J. Neurochem. 105, 2343-2352
20. Puig, B., Rey, M.J. and Ferrer, I. (2005) Individual and regional variations of phospho-tau species in progressive supranuclear palsy. Acta Neuropathol. 110, 261-268
21. Borroni, B., Gardoni, F., Parnetti, L., Magno, L., Malinverno, M., Saggese, E., Calabresi, P., Spillantini, M.G., Padovani, A. and Di Luca, M. (2009) Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol. Aging 30, 34-40
22. Johnson, G.V.W., Jope, R.S. and Binder, L.I. (1989) Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163, 1505-1511
23. Arai, T., Guo, J.P. and McGeer, P.L. (2005) Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J. Biol. Chem. 280, 5145-5153
24. Kenessey, A., Nacharaju, P., Ko, L.W. and Yen, S.H. (1997) Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69, 2026-2038
25. Sengupta, S., Horowitz, P.M., Karsten, S.L., Jackson, G.R., Geschwind, D.H., Fu, Y., Berry, R.W. and Binder, L.I. (2006) Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. Biochemistry 45, 15111-15119
26. Fasulo, L., Ugolini, G., Visintin, M., Bradbury, A., Brancolini, C., Verzillo, V., Novak, M. and Cattaneo, A. (2000) The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75, 624-633
27. Chung, C.W., Song, Y.H., Kim, I.K., Yoon, W.J., Ryu, B.R., Jo, D.G., Woo, H.N., Kwon, Y.K., Kim, H.H., Gwag, B.J. et al. (2001) Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis. 8, 162-172
28. Fasulo, L., Ugolini, G. and Cattaneo, A. (2005) Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K. J. Alzheimer's Dis. 7, 3-13
29. Horowitz, P.M., Patterson, K.R., Guillozet-Bongaarts, A.L., Reynolds, M.R., Carroll, C.A., Weintraub, S.T., Bennett, D.A., Cryns, V.L., Berry, R.W. and Binder, L.I. (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24, 7895-7902
30. Yang, L.S. and Ksiezak-Reding, H. (1995) Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233, 9-17
31. Litersky, J.M. and Johnson, G.V.W. (1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267, 1563-1568
32. Mercken, M., Grynspan, F. and Nixon, R.A. (1995) Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett. 368, 10-14
33. Yen, S., Easson, C., Nacharaju, P., Hutton, M. and Yen, S.H. (1999) FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. FEBS Lett. 461, 91-95
34. Saito, K., Elce, J.S., Hamos, J.E. and Nixon, R.A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 90, 2628-2632
35. Rao, M.V., Mohan, P.S., Peterhoff, C.M., Yang, D.S., Schmidt, S.D., Stavrides, P.H., Campbell, J., Chen, Y., Jiang, Y., Paskevich, P.A. et al. (2008) Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J. Neurosci. 28, 12241-12254
36. Akiyama, H., Ikeda, K., Kondo, H. and McGeer, P.L. (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146, 152-154
37. Wang, Y.P., Biernat, J., Pickhardt, M., Mandelkow, E. and Mandelkow, E.M. (2007) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc. Natl. Acad. Sci. U.S.A. 104, 10252-10257
38. Olesen, O.F. (1994) Proteolytic degradation of microtubule associated protein tau by thrombin. Biochem. Biophys. Res. Commun. 201, 716-721
39. Arai, T., Miklossy, J., Klegeris, A., Guo, J.P. and McGeer, P.L. (2006) Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 65, 19-25
40. Wang, X., An, S. and Wu, J.M. (1996) Specific processing of native and phosphorylated tau protein by proteases. Biochem. Biophys. Res. Commun. 219, 591-597
41. Nakanishi, H., Amano, T., Sastradipura, D.F., Yoshimine, Y., Tsukuba, T., Tanabe, K., Hirotsu, I., Ohono, T. and Yamamoto, K. (1997) Increased expression of cathepsins E and D in neurons of the aged rat brain and their colocalization with lipofuscin and carboxy-terminal fragments of Alzheimer amyloid precursor protein. J. Neurochem. 68, 739-749
42. Cataldo, A.M., Barnett, J.L., Pieroni, C. and Nixon, R.A. (1997) Increased neuronal endocytosis and protease delivery to early endosomes in\ sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J. Neurosci. 17, 6142-6151
43. Hamano, T., Gendron, T.F., Causevic, E., Yen, S.H., Lin, W.L., Isidoro, C., DeTure, M. and Ko, L.W. (2008) Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur. J. Neurosci. 27, 1119-1130
44. Karsten, S.L., Sang, T.K., Gehman, L.T., Chatterjee, S., Liu, J., Lawless, G.M., Sengupta, S., Berry, R.W., Pomakian, J., Oh, H.S. et al. (2006) A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron 51, 549-560
45. Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von, B.M., Gazova, Z., Mandelkow, E. and Mandelkow, E.M. (2006) Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J. Biol. Chem. 281, 1205-1214
46. Mocanu, M.M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., Petrova, O., Schonig, K., Bujard, H., Mandelkow, E. et al. (2008) The potential for β-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748
47. Momeni, P., Pittman, A., Lashley, T., Vandrovcova, J., Malzer, E., Luk, C., Hulette, C., Lees, A., Revesz, T., Hardy, J. and de Silva, R. (2009) Clinical and pathological features of an Alzheimer's disease patient with the MAPT ΔK280 mutation. Neurobiol. Aging 30, 388-393
48. Zilka, N., Filipcik, P., Koson, P., Fialova, L., Skrabana, R., Zilkova, M., Rolkova, G., Kontsekova, E. and Novak, M. (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett. 580, 3582-3588
49. Hrnkova, M., Zilka, N., Minichova, Z., Koson, P. and Novak, M. (2007) Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Res. 1130, 206-213
50. Zhang, Q., Zhang, X. and Sun, A. (2009) Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Acta Neuropathol. 117, 687-697
51. Delobel, P., Lavenir, I., Fraser, G., Ingram, E., Holzer, M., Ghetti, B., Spillantini, M.G., Crowther, R.A. and Goedert, M. (2008) Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am. J. Pathol. 172, 123-131